SCHEMBL26693247

SCHEMBL26693247

Fc1[nH]c2cccc(F)c2c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.46
FFAR1 O14842 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
HTR2A P28223 2/20 0.39
DAO P14920 2/20 0.36
DDO Q99489 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
PARP1 P09874 2/20 0.34
CNR1 P21554 1/20 0.33
PDE7A Q13946 1/20 0.33
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
IMPDH2 P12268 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9851537 0.84 FEN1 (0.49) FEN1FFAR1GPR84HTR2ADAO
SCHEMBL12836459 0.80 FEN1 (0.52) FEN1FFAR1GPR84HTR2ADAO
Butyric Acid SCHEMBL9251506 0.79 SMN1; SMN2 (0.40) FEN1ALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL9128769 0.77 FEN1 (0.50) FEN1FFAR1GPR84HTR2ADAO
SCHEMBL1071125 0.74 GPR84 (0.44) GPR84HTR2ADAO
SCHEMBL28016595 0.74 CNR1 (0.50) FEN1FFAR1GPR84PARP1CNR1
SCHEMBL6035404 0.73 GPR84 (0.42) GPR84HTR2ADAO
SCHEMBL29879228 0.71 IMPDH2 (0.59) FEN1PARP1PDE7ANPC1ALDH1A1
SCHEMBL12836461 0.71 IMPDH2 (0.59) FEN1PARP1PDE7ANPC1ALDH1A1
SCHEMBL7041118 0.69 KDM4E (0.50) FEN1DAODDOPARP1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459388-A Indole benzoquinone derivative and preparation method and application thereof 四川大学 2024-08-09 CN claimed
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS UNIV DANMARKS TEKNISKE (DK) 2025-11-20 US disclosed
EP-4526426-A2 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS Danmarks Tekniske Universitet (DK) 2025-03-26 EP disclosed
CN-118459388-B Indole benzoquinone derivative and preparation method and application thereof 四川大学 2024-09-03 CN disclosed
CN-118459388-A Indole benzoquinone derivative and preparation method and application thereof 四川大学 2024-08-09 CN disclosed
US-20240150313-A1 TRI-SUBSTITUTED INDOLE BINDING FUNCTION 3 (BF3) COMPOUNDS AND METHODS FOR THEIR USE UNIV BRITISH COLUMBIA (CA) 2024-05-09 US disclosed
EP-4323372-A1 TRI-SUBSTITUTED INDOLE BINDING FUNCTION 3 (BF3) COMPOUNDS AND METHODS FOR THEIR USE The University Of British Columbia (CA) 2024-02-21 EP disclosed
WO-2023222879-A2 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-23 WO disclosed
CN-112041300-B Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists 阿达梅德制药公司 2023-07-28 CN disclosed
WO-2022219541-A1 TRI-SUBSTITUTED INDOLE BINDING FUNCTION 3 (BF3) COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2022-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150313-A1 TRI-SUBSTITUTED INDOLE BINDING FUNCTION 3 (BF3) COMPOUNDS AND METHODS FOR THEIR USE KLK3, BRDT, HTR3A FEN1 512/4885FFAR1 1378/4885GPR84 1866/4885
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS INMT, KARS1, MIA3 FEN1 1031/4885FFAR1 1970/4885GPR84 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.